Skip to content

Observation on the efficacy of phased 3DEEP radiofrequency therapy for rosacea with erythematous telangiectasia

Observation on the efficacy of phased 3DEEP radiofrequency therapy for rosacea with erythematous telangiectasia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097577
Enrollment
Unknown
Registered
2025-02-21
Start date
2023-09-09
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Intense pulsed light treatment group:None
Radio frequency therapy group:None

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Clinical diagnosis conforms to the 2021 consensus of Chinese rose acne diagnosis and treatment experts; 2.Continuous oral administration of rose acne medication for 3 months or more before treatment, with complaints of facial redness and discomfort; 3.Regularly complete 6 radio frequency treatments, with complete examination results and scoring data;

Exclusion criteria

Exclusion criteria: 1.Age<18 years old, lack the ability to think independently and answer questions; 2.Poor compliance during treatment and lack of cooperation with patients;

Design outcomes

Primary

MeasureTime frame
Clinician Erythema Assessment Score (CEA);Monthly skin physiological function test;Investigator Overall Assessment (IGA),;

Secondary

MeasureTime frame
Dermatology Quality of Life index;

Countries

China

Contacts

Public ContactGe Lan

The First Affiliated Hospital of Army Medical University

43793340@qq.com+86 23 68765784

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026